Our 2024 team is currently full. 

The ADDF is proud to be an official charity partner for the 2024 TCS New York City Marathon. The TCS New York City Marathon is more than a marathon. It’s a journey that starts long before the last 26.2 miles. It’s 50,000 runners in the greatest city in the world, joined together across 5 boroughs with one goal in mind—to help you cross the finish line.

By running on the ADDF's Runner’s For Alzheimer’s Research team, you have the opportunity to make your miles meaningful and support ADDF's work to rapidly accelerate the development of drugs to prevent, treat and cure Alzheimer's disease.

Donations to our team directly support research into new treatments for this devastating disease. A full 100% of every dollar donated to us goes directly to science. The ADDF's leadership and contributions to the field have played a pivotal role in bringing the first Alzheimer's PET scan (Amyvid®) and blood test (PrecivityAD®) to market, as well as fueling the current robust and diverse drug pipeline. Through the generosity of its donors, the ADDF has awarded more than $290 million to fund over 750 Alzheimer's drug discovery programs, biomarker programs and clinical trials in 20 countries.